Physician profile
Ryan Halickman
NPI 1992156319
$325.80
in general payments reported to CMS, 2019-2025
9 companies · $88.74 in 2025
The $88.74 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.51 · 2024: $226 · 2025: $88.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $99.99 | 2024 | (Ck4) Mcot, (Ck7) Extended Holter |
| Boston Scientific Corporation | $52.33 | 2024-2025 | General - Therapies |
| Abbott Laboratories | $33.96 | 2024 | Amplatzer Piccolo |
| Sobi, INC | $31.27 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $27.44 | 2025 | Opsumit, Opsynvi, Uptravi |
| Altathera Pharmaceuticals LLC | $24.33 | 2025 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals International, Plc | $23.87 | 2024 | Arcalyst |
| Ani Pharmaceuticals, INC. | $21.10 | 2024 | Purified Cortrophin Gel |
| W. L. Gore & Associates, INC. | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Halickman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.